CIK: 1392029 - Address: C/O Chromocell Therapeutics Corporation, 4400 Route 9 South, Suite 1000, Freehold, NJ 07728
24 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret11157324264820
P%wins100100100100100100100
S%ret111-6-12-17-15-33-2-14
S%wins100100100100100100100

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
8/9/24 17:52
8/8/24
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsDavis Todd CFLDOCEOP24397.39032123D
3/27/24 17:47
3/25/24
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsDavis Todd CFLDOCEOM.d91957.3901615120D
2/23/24 17:15
2/21/24
CHROChromocell Therapeutics CorpDEHealthBioPrdBiological Products, (No DiagDavis Todd CNJDM.d1404.80029New29D
9/25/23 16:44
9/22/23
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsDavis Todd CCADOCEOP23859.3804673D
2/1/22 16:06
1/27/22
BDSIBiodelivery Sciences International IncDEHealthDrugPharmaceutical PreparationsDavis Todd CNCDM.d00.00083252D
8/10/21 18:15
8/6/21
BDSIBiodelivery Sciences International IncDEHealthDrugPharmaceutical PreparationsDavis Todd CNCDM.d00.0003014245D
2/12/21 18:23
2/10/21
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsDavis Todd CCADS.d-1,083213.140-5-950D
2/12/21 18:23
2/11/21
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsDavis Todd CCADM.d485195.9102550D
1/27/21 19:02
1/27/21
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsDavis Todd CCADM.d279113.5002553D
8/20/20 16:16
8/18/20
BDSIBiodelivery Sciences International IncDEHealthDrugPharmaceutical PreparationsDavis Todd CNCDS-2504.990-50-19218D
8/11/20 16:50
8/7/20
BDSIBiodelivery Sciences International IncDEHealthDrugPharmaceutical PreparationsDavis Todd CNCDM.d00.0003013268D
4/30/20 16:10
4/28/20
VXRTVaxart, Inc.DEHealthBioPrdBiological Products, (No DiagDavis Todd CCADS-1973.280-60-33120D
11/19/19 16:38
11/15/19
BDSIBiodelivery Sciences International IncDEHealthDrugPharmaceutical PreparationsDavis Todd CNCDS-1,2226.110-200-46238D
8/15/19 16:27
8/13/19
BDSIBiodelivery Sciences International IncDEHealthDrugPharmaceutical PreparationsDavis Todd CNCDM.d00.000184438D
8/5/19 19:04
8/2/19
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsDavis Todd CCADP9493.5901249D
10/15/18 12:55
10/12/18
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsDavis Todd CCADM.d525103.29051248D
10/9/18 16:24
10/8/18
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsDavis Todd CCADS-635253.990-3-643D
8/17/18 19:38
8/16/18
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsDavis Todd CCADS.m-2,158239.780-9-1745D
8/16/18 17:00
8/14/18
BDSIBiodelivery Sciences International IncDEHealthDrugPharmaceutical PreparationsDavis Todd CNCDM.d00.0003New3D
2/27/18 18:39
2/26/18
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsDavis Todd CCADS.m-2,616152.370-17-2454D
11/1/16 20:18
10/31/16
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsDavis Todd CCADM.d63845.6629142570D766-20-28-18-301-2-291016
8/6/15 19:49
8/6/15
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsDavis Todd CCADM.d23211.8132205555D1371101064212683-10-8-14-9-525
3/20/14 18:40
3/18/14
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsDavis Todd CCADS.m-59779.5727-8-1933D3772316550369113-6-12-17-15-33-2
8/11/11 20:08
8/10/11
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsDavis Todd CCADP16410.9021510629D-3820241-6-9-18-4573242648

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact